Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno François, Robin Jeannet, Thomas Daix, et al.
JCI Insight (2018) Vol. 3, Iss. 5
Open Access | Times Cited: 325

Showing 26-50 of 325 citing articles:

Precision Immunotherapy for Sepsis
Annemieke M. Peters van Ton, Matthijs Kox, Wilson F. Abdo, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 137
CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State
Matthew D. Martin, Vladimir P. Badovinac, Thomas S. Griffith
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 126
Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series
Didier Payen, Valérie Faivre, Jordi Miatello, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 108
Micronutrients as immunomodulatory tools for COVID-19 management
Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, et al.
Clinical Immunology (2020) Vol. 220, pp. 108545-108545
Open Access | Times Cited: 104
Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway
Yuki Nakamori, Eun Jeong Park, Motomu Shimaoka
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 100
Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis
McKenzie K. Hollen, Julie A. Stortz, Dijoia B. Darden, et al.
Critical Care (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 88
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
Pierre François Laterre, Bruno François, Christine Collienne, et al.
JAMA Network Open (2020) Vol. 3, Iss. 7, pp. e2016485-e2016485
Open Access | Times Cited: 85
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy
Philippe Lambin, R. Lieverse, Franziska Eckert, et al.
Seminars in Radiation Oncology (2020) Vol. 30, Iss. 2, pp. 187-193
Open Access | Times Cited: 84
The Critical Roles and Mechanisms of Immune Cell Death in Sepsis
Zhenxing Cheng, Simon T. Abrams, Julien Toh, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 79
Role of the adaptive immune response in sepsis
Jack Brady, Shahd Horie, John G. Laffey
Intensive Care Medicine Experimental (2020) Vol. 8, Iss. S1
Open Access | Times Cited: 79
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression
Robin Jeannet, Thomas Daix, Rémy Formento, et al.
Intensive Care Medicine (2020) Vol. 46, Iss. 9, pp. 1769-1771
Open Access | Times Cited: 75
Towards efficient immunotherapy for bacterial infection
Timothy R. McCulloch, Timothy J. Wells, Fernando Souza-Fonseca-Guimarães
Trends in Microbiology (2021) Vol. 30, Iss. 2, pp. 158-169
Open Access | Times Cited: 75
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
Miriam Kim, Reyka G. Jayasinghe, Jessica M. Devenport, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
IL-7: Comprehensive review
Hila Winer, Gisele Rodrigues, Julie A. Hixon, et al.
Cytokine (2022) Vol. 160, pp. 156049-156049
Closed Access | Times Cited: 62
Dysregulated Immunity and Immunotherapy after Sepsis
Dijoia B. Darden, Lauren S. Kelly, Brittany P. Fenner, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1742-1742
Open Access | Times Cited: 59
Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
Ren-qi Yao, Chao Ren, Liyu Zheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Immune modulation after traumatic brain injury
Marwan Bouras, Karim Asehnoune, Antoine Roquilly
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 45
MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets
Wanying Zhang, Xiangzhi Fang, Chenggang Gao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 69, pp. 90-103
Open Access | Times Cited: 43
The End of “One Size Fits All” Sepsis Therapies: Toward an Individualized Approach
Jean‐Louis Vincent, Tom van der Poll, John C. Marshall
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2260-2260
Open Access | Times Cited: 41
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
Thomas Daix, Armelle Mathonnet, Scott C. Brakenridge, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms
A. M. Marques, Carla Torre, Rui Pinto, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2892-2892
Open Access | Times Cited: 32
The pathogenesis and potential therapeutic targets in sepsis
Wendan Zhang, Honghong Jiang, Gaosong Wu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 31
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
Ila Joshi, Walter P. Carney, Edwin P. Rock
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
Carlos Henrique Nery Costa, Kwang-Poo Chang, Dorcas Lamounier Costa, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 969-969
Open Access | Times Cited: 25

Scroll to top